top of page

President Biden signs executive order to boost biotech


Photo Credit: Gage Skidmore

As a result of China's aggressive investment in biotechnology, which poses a threat to U.S. competitiveness, President Joe Biden has signed an executive order aimed at boosting biotech production and research in the United States, according to a senior administration official.


Biden signed the order on Sept. 12 launching the National Biotechnology and Biomanufacturing Initiative (NBBI) and that the initiative will "ensure all the inventions in the United States can be manufactured here."


The White House said the initiative aims to promote biomanufacturing in industries such as pharmaceuticals, agriculture, and plastics.


In response to this, other countries, including China, have invested heavily in biotech in order to dominate the market and become the primary provider of biotech solutions and products around the world.


Using industry analyses as a source, the White House predicted that bioengineering could account for more than a third of global manufacturing output by the turn of the century. Value-wise, this amounts to nearly $30 trillion.


According to the White House, we have relied too heavily on foreign materials and bioproduction, and our off-shoring of critical industries, such as biotechnology, has threatened our ability to obtain materials like important chemicals and active pharmaceutical ingredients.



12 Sep 2022

 
 
 

Comentarios


Contact us

Letter to Editor-In-Chief
Editor@capitoltimesmedia.com

For Advertising in
Capitol Times Magazine:

ads@capitoltimesmedia.com

Capitol Times magazine Issue 5
Capitol times magazine 9
Capitol times magazine 10

Join our mailing list

FOLLOW US

Disclaimer:

The views and opinions expressed in the articles or Interviews published in this magazine are solely those of the respective authors and do not necessarily reflect the official policy or position of the Capitol Times magazine or Capitol Times Media , its editors, or its staff. The authors are solely responsible for the content of their articles. The magazine strives to provide a platform for diverse voices and opinions, and we value the principle of free expression. The magazine assumes no responsibility or liability for any errors or omissions in the content of the articles. In no event shall the Capitol Times magazine or Capitol Times Media be liable for any special, direct, indirect, or incidental damages. Furthermore, the inclusion of advertisements or sponsored content in Capitol Times magazine does not constitute an endorsement or guarantee of the products, services, or views promoted by the advertisers. Readers are encouraged to conduct their own research and exercise caution when making decisions based on advertisements or sponsored content featured in this publication.

Thank you for reading and engaging with our publication. Your feedback is valuable to us as we continue to provide a platform for thought-provoking content and diverse perspectives.

© 2025 by Capitol Times Media LLC - Privacy Policy

  • X
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
bottom of page